The molecular basis of thrombolysis and its clinical application in stroke.

Murray, V; Norrving, B; Sandercock, P A G; Terént, A; Wardlaw, J M; Wester, P

Murray, V; Norrving, B; Sandercock, P A G; Terént, A; Wardlaw, J M; Wester, P.

Affiliation

Murray V; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, SE-182 88 Stockholm, Sweden. veronica.murray@ki.se

J Intern Med ; 267(2): 191-208, 2010 Feb.

Article in En | MEDLINE | ID: mdl-20175866

Subject(s)

Brain Ischemia/drug therapy; Fibrinolytic Agents/therapeutic use; Stroke/drug therapy; Thrombolytic Therapy; Acute Disease; Animals; Brain Ischemia/complications; Brain Ischemia/mortality; Hemorrhage/etiology; Humans; Licensure; Patient Acceptance of Health Care; Stroke/complications; Stroke/mortality

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombolytic Therapy / Brain Ischemia / Stroke / Fibrinolytic Agents Type of study: Clinical_trials / Etiology_studies Limits: Animals / Humans Language: En Journal: J Intern Med Journal subject: MEDICINA INTERNA Year: 2010 Type: Article Affiliation country: Sweden

Fulltext

XML

PubMed Links

Search on Google